ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1617

Burden of Adverse Childhood Experiences in Pediatric Chronic Pain and Rheumatic Disease

Maitry Sonagra1, Jeremy Jones2, Mackenzie McGill3 and Sabrina Gmuca3, 1Seattle Children's Hospital, Seattle, WA, 2University of Pennsylvania, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: ACR Convergence 2021

Keywords: ACE, pain, Pediatric rheumatology, physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Pediatric Rheumatology – Clinical Poster III: Miscellaneous Rheumatic Disease (1614–1644)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Adverse childhood experiences (ACEs) serve as stressors that can have negative, lasting effects on health and wellbeing. While there has been increasing evidence to suggest an etiologic role of ACEs in pediatric chronic pain and rheumatic disease, our understanding of how ACEs may shape a child’s clinical presentation remains limited. We aimed to determine 1) the association between the presence of ACEs and clinical manifestations of pediatric chronic pain and 2) explore the interaction of ACEs and pediatric rheumatic disease among youth with chronic pain on health-related outcomes.

Methods: This was a retrospective cross-sectional cohort study of patients 3-18 years old with chronic pain seen in a pediatric rheumatology pain clinic between August 2018 and July 2020 and previously enrolled in a patient registry. Abstracted clinical data included demographics, past medical, psychological, and social histories, as well as patient reported outcome (PRO) measures including: functional disability inventory (FDI; 0-60), verbal pain report (0-10), symptom severity score (SSS; 0-12) and widespread pain index (WPI; 0-19). We stratified our sample into three groups: no ACEs, one ACE and ≥2 ACEs. We assessed clinical signs and symptoms associated with the presence of ACEs using Chi-square or Wilcoxon-rank tests. The association between ACEs and functional impairment was tested using simple and multivariable linear regression.

Results: A total of 412 patients were included in the study. More than 75% of patients reported at least one ACE. The most frequently reported ACEs included history of mental illness in a first degree relative (56%) and parental divorce or separation (20%). Those with ≥2 ACEs had more somatic symptoms, worse physical function, and a higher proportion of comorbid mental health conditions than those with no or one ACE (Table 1). Bivariate linear regression indicated positive linear association of patient physical disability (FDI) with WPI, SSS, and verbal pain (all p< 0.05; Table 2). Moreover, presence of mental health conditions and autonomic changes were associated with increased FDI scores in patients. Dose dependent interaction between ACEs and co-morbid rheumatologic conditions was found. As compared to the no ACE group, those with one or more than two ACEs were found to have an additional increase in FDI score by 8.5 and 11 points, respectively, for each additional rheumatologic condition. In multivariable regression (Table 3), higher verbal pain score, symptom severity score and presence of autonomic changes were independently associated with estimated average increase in FDI score by 1.05, 1.95 and 4.76 respectively (all p< 0.01). The interaction demonstrating worsened functional impairment from rheumatologic disease for those with ACEs was again observed.

Conclusion: Children with chronic pain and/or rheumatologic diseases who are exposed to ACEs are at increased risk of worse disability, greater symptom severity, and a higher burden of co-morbid mental health conditions. Our findings indicate an ongoing need for systemic evaluation of ACEs exposure in children with chronic pain and/or rheumatic disease and incorporation of trauma-based care.


Disclosures: M. Sonagra, None; J. Jones, None; M. McGill, None; S. Gmuca, None.

To cite this abstract in AMA style:

Sonagra M, Jones J, McGill M, Gmuca S. Burden of Adverse Childhood Experiences in Pediatric Chronic Pain and Rheumatic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/burden-of-adverse-childhood-experiences-in-pediatric-chronic-pain-and-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/burden-of-adverse-childhood-experiences-in-pediatric-chronic-pain-and-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology